{"id":79419,"date":"2026-09-08T12:53:10","date_gmt":"2026-09-08T04:53:10","guid":{"rendered":"https:\/\/flcube.com\/?p=79419"},"modified":"2026-09-08T12:53:11","modified_gmt":"2026-09-08T04:53:11","slug":"liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate","status":"publish","type":"post","link":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/","title":{"rendered":"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Liaocheng University<\/strong> and <strong>Shanghai Maiboxing Biotechnology Co., Ltd.<\/strong> have signed a <strong>cooperation agreement totaling RMB 19 million<\/strong> to jointly advance the <strong>collaborative R&amp;D and industrialization of LCUGZ1007<\/strong>, a <strong>next\u2011generation E\u2011PDC (Enhanced Probody Drug Conjugate)<\/strong> drug.<\/p>\n\n\n\n<h2 id=\"h-deal-milestone\" class=\"wp-block-heading\">Deal Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Parties<\/strong><\/td><td>Liaocheng University &amp; Shanghai Maiboxing Biotechnology Co., Ltd.<\/td><\/tr><tr><td><strong>Agreement Type<\/strong><\/td><td>Cooperation agreement \u2014 joint R&amp;D and industrialization<\/td><\/tr><tr><td><strong>Total Value<\/strong><\/td><td><strong>RMB 19 million<\/strong><\/td><\/tr><tr><td><strong>Asset<\/strong><\/td><td><strong>LCUGZ1007<\/strong> \u2014 next\u2011generation E\u2011PDC (Enhanced Probody Drug Conjugate)<\/td><\/tr><tr><td><strong>Current Stage<\/strong><\/td><td>Systematic preclinical evaluation completed<\/td><\/tr><tr><td><strong>Development Goal<\/strong><\/td><td>Enter clinical trial stages as soon as possible<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-technology-profile-amp-mechanism-of-action\" class=\"wp-block-heading\">Technology Profile &amp; Mechanism of Action<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Modality:<\/strong> <strong>E\u2011PDC (Enhanced Probody Drug Conjugate)<\/strong> \u2014 a next\u2011generation evolution of antibody\u2013drug conjugate (ADC) technology<\/li>\n\n\n\n<li><strong>Core Innovation \u2014 &#8220;Probody Technology&#8221;:<\/strong> A specialized molecular design keeps the antibody in an <strong>inactive &#8220;dormant state&#8221; in normal tissues<\/strong>, activating only <strong>within the tumor microenvironment<\/strong><\/li>\n\n\n\n<li><strong>Safety Advantage vs. Traditional ADCs:<\/strong> Significantly <strong>reduces off\u2011target toxicity<\/strong> and <strong>avoids damage to normal tissues<\/strong> \u2014 addressing a key limitation that has constrained ADC tolerability and dosing<\/li>\n\n\n\n<li><strong>Development Status:<\/strong> LCUGZ1007 has completed <strong>systematic preclinical evaluation<\/strong> and is currently advancing <strong>optimization and translational research<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Next Wave Beyond ADCs:<\/strong> Antibody\u2013drug conjugates have become one of oncology&#8217;s hottest asset classes, but off\u2011target toxicity remains a leading cause of dose limitation and clinical failure. Tumor\u2011microenvironment\u2011activated probody designs are emerging as a differentiated next generation.<\/li>\n\n\n\n<li><strong>Industry\u2013Academia Industrialization:<\/strong> The RMB 19 million agreement pairs Liaocheng University&#8217;s research output with Shanghai Maiboxing Biotechnology&#8217;s development platform, targeting a full path from bench to <strong>industrialization<\/strong>.<\/li>\n\n\n\n<li><strong>Clinical Timeline:<\/strong> With preclinical evaluation complete, the program&#8217;s stated objective is to <strong>enter clinical trials as soon as possible<\/strong>, positioning LCUGZ1007 among the early assets in the E\u2011PDC class.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding preclinical optimization, translational research, clinical trial entry, and industrialization of LCUGZ1007. Actual results may differ due to risks including research outcomes, regulatory timelines, funding, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Liaocheng University and Shanghai Maiboxing Biotechnology Co., Ltd. have signed a cooperation agreement totaling RMB&#8230;<\/p>\n","protected":false},"author":1,"featured_media":79425,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10,4908],"tags":[35,4940],"class_list":["post-79419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-pic","tag-adc-xdc","tag-maiboxing-biotechnology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Liaocheng University and Shanghai Maiboxing Biotechnology Co., Ltd. have signed a cooperation agreement totaling RMB 19 million to jointly advance the collaborative R&amp;D and industrialization of LCUGZ1007, a next\u2011generation E\u2011PDC (Enhanced Probody Drug Conjugate) drug.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate\" \/>\n<meta property=\"og:description\" content=\"Liaocheng University and Shanghai Maiboxing Biotechnology Co., Ltd. have signed a cooperation agreement totaling RMB 19 million to jointly advance the collaborative R&amp;D and industrialization of LCUGZ1007, a next\u2011generation E\u2011PDC (Enhanced Probody Drug Conjugate) drug.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-08T04:53:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T04:53:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0803.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate\",\"datePublished\":\"2026-09-08T04:53:10+00:00\",\"dateModified\":\"2026-09-08T04:53:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/\"},\"wordCount\":349,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0803.webp\",\"keywords\":[\"ADC \\\/ XDC\",\"Maiboxing Biotechnology\"],\"articleSection\":[\"Company\",\"Deals\",\"PIC\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/\",\"name\":\"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0803.webp\",\"datePublished\":\"2026-09-08T04:53:10+00:00\",\"dateModified\":\"2026-09-08T04:53:11+00:00\",\"description\":\"Liaocheng University and Shanghai Maiboxing Biotechnology Co., Ltd. have signed a cooperation agreement totaling RMB 19 million to jointly advance the collaborative R&D and industrialization of LCUGZ1007, a next\u2011generation E\u2011PDC (Enhanced Probody Drug Conjugate) drug.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0803.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/0803.webp\",\"width\":1080,\"height\":608,\"caption\":\"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/author\\\/wesley\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate - Insight, China&#039;s Pharmaceutical Industry","description":"Liaocheng University and Shanghai Maiboxing Biotechnology Co., Ltd. have signed a cooperation agreement totaling RMB 19 million to jointly advance the collaborative R&D and industrialization of LCUGZ1007, a next\u2011generation E\u2011PDC (Enhanced Probody Drug Conjugate) drug.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/","og_locale":"en_US","og_type":"article","og_title":"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate","og_description":"Liaocheng University and Shanghai Maiboxing Biotechnology Co., Ltd. have signed a cooperation agreement totaling RMB 19 million to jointly advance the collaborative R&D and industrialization of LCUGZ1007, a next\u2011generation E\u2011PDC (Enhanced Probody Drug Conjugate) drug.","og_url":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-09-08T04:53:10+00:00","article_modified_time":"2026-09-08T04:53:11+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0803.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/#article","isPartOf":{"@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate","datePublished":"2026-09-08T04:53:10+00:00","dateModified":"2026-09-08T04:53:11+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/"},"wordCount":349,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0803.webp","keywords":["ADC \/ XDC","Maiboxing Biotechnology"],"articleSection":["Company","Deals","PIC"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/","url":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/","name":"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0803.webp","datePublished":"2026-09-08T04:53:10+00:00","dateModified":"2026-09-08T04:53:11+00:00","description":"Liaocheng University and Shanghai Maiboxing Biotechnology Co., Ltd. have signed a cooperation agreement totaling RMB 19 million to jointly advance the collaborative R&D and industrialization of LCUGZ1007, a next\u2011generation E\u2011PDC (Enhanced Probody Drug Conjugate) drug.","breadcrumb":{"@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0803.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0803.webp","width":1080,"height":608,"caption":"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/liaocheng-university-and-shanghai-maiboxing-biotechnology-sign-rmb-19-million-pact-to-co-develop-lcugz1007-next-generation-e-pdc-probody-drug-conjugate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Liaocheng University and Shanghai Maiboxing Biotechnology Sign RMB 19 Million Pact to Co\u2011Develop LCUGZ1007 \u2013 Next\u2011Generation E\u2011PDC Probody Drug Conjugate"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/author\/wesley\/"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/09\/0803.webp","_links":{"self":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts\/79419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/comments?post=79419"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts\/79419\/revisions"}],"predecessor-version":[{"id":79426,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/posts\/79419\/revisions\/79426"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/media\/79425"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/media?parent=79419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/categories?post=79419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/wp-json\/wp\/v2\/tags?post=79419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}